Hubert, Violaine
Dumot, Chloé
Ong, Elodie
Amaz, Camille
Canet-Soulas, Emmanuelle
Chauveau, Fabien http://orcid.org/0000-0002-4177-741X
Wiart, Marlène
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-15-CE18-0026-01, ANR-15-CE18-0026-01, ANR-16-RHUS-0009)
Article History
Received: 21 January 2019
Accepted: 25 June 2019
First Online: 11 July 2019
Competing Interests
: This project is the subject of an agreement between AMAG pharmaceuticals and Marlène Wiart regarding the use of Ferumoxytol to study neuroinflammation. AMAG pharmaceuticals did not participate in the design of the study nor in the interpretation of data. Otherwise, the authors declare that the research was conducted in the absence of any commercial, financial or non-financial relationships that could be construed as a potential conflict of interest.